Clinical Trials

Study Title:
A Phase 1B Trial of Tarloxotinib and Sotorasib in Patients with KRAS G12C Mutations

For more information about the trial above please contact the study team:

Principal Investigator, Mariam Alexander, at alexanma@musc.edu.

Study Coordinator, Alexandra Leitner, at leitnera@musc.edu, or please call +1 843-792-1507.

Trial opened at the following institutions: Medical University of South Carolina